71 filings
6-K
MOLN
Molecular Partners Ag
14 Jun 24
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EHA 2024
10:44am
6-K
MOLN
Molecular Partners Ag
11 Jun 24
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
10:16am
6-K
MOLN
Molecular Partners Ag
3 Jun 24
Current report (foreign)
5:06pm
6-K/A
MOLN
Molecular Partners Ag
17 May 24
Current report (foreign) (amended)
6:25am
6-K
MOLN
Molecular Partners Ag
16 May 24
Current report (foreign)
4:00pm
6-K
ftt wldgm7ug
26 Mar 24
Molecular Partners Publishes Invitation to Annual General Meeting 2024
9:34am
6-K
v10p7ucp tqk8s6
8 Jan 24
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
12:33pm
6-K
8mqx6umbbb mi5whip36
5 Jan 24
Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
4:00pm
6-K
3h3fwe
11 Dec 23
Current report (foreign)
6:05am
6-K
o7rk8msdfa45c2zluw2
2 Nov 23
Current report (foreign)
6:01am
6-K
1pnjfsdsgkkdyw 64x
26 Oct 23
Current report (foreign)
4:00pm
6-K
l2ass8i p6
24 Aug 23
Molecular Partners Reports H1 2023 Corporate Highlights and Financials
4:02pm
S-8
swlv1o3b3 22i
28 Jun 23
Registration of securities for employees
8:34am
6-K
hkb0xez7qyg
12 May 23
Current report (foreign)
6:05am
6-K
e02ij0kb0b7ucpyi8o
11 May 23
Current report (foreign)
4:00pm
6-K
jww2d2 la490h3f
13 Mar 23
Molecular Partners Publishes Invitation to Annual General Meeting 2023
9:30am
6-K
jcxjvgt3icrbql9x59
9 Mar 23
Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022
4:00pm
6-K
hx3nznuh22
17 Jan 23
Current report (foreign)
7:00am